P53 status and its prognostic role in extrahepatic bile duct cancer: A meta-analysis of published studies

Digestive Diseases and Sciences

Volumn 56, Issue 3, 2011, Pages 655-662

  Wang, Juan ^a   Wang, Xuefeng ^b   Xie, Shuyang ^a   Yan, Zhonghai ^c   Li, Zunling ^a   Li, Youjie ^a   Wang, Lei ^d   Jiao, Fei ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Extrahepatic bile duct cancer; Meta analysis; p53; Prognosis

Indexed keywords

PROTEIN P53;

ADULT; AGED; BILE DUCT CANCER; CANCER STAGING; CANCER SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; META ANALYSIS; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CLINICAL TRIALS AS TOPIC; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952445069     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1352-9     Document Type: Review

References (48)

1. DS Sandhu LR Roberts 2008 Diagnosis and management of cholangiocarcinoma Curr Gastroenterol Rep 10 43 52 10.1007/s11894-008-0008-9 18417042
2. CD Briggs CP Neal CD Mann, et al. 2009 Prognostic molecular markers in cholangiocarcinoma: a systematic review Eur J Cancer 45 33 47 1:CAS:528:DC%2BD1cXhsFahur%2FP 10.1016/j.ejca.2008.08.024 18938071
3. TM Welzel KA McGlynn AW Hsing, et al. 2006 Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States J Natl Cancer Inst 98 873 875 10.1093/jnci/djj234 16788161 (Pubitemid 43923444)
4. B Blechacz GJ Gores 2008 Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 308 321 1:CAS:528:DC%2BD1cXptFemu70%3D 10.1002/hep.22310 18536057 (Pubitemid 351975555)
5. GK Bonney RA Craven R Prasad, et al. 2008 Circulating markers of biliary malignancy: opportunities in proteomics? Lancet Oncol 9 149 158 1:CAS:528:DC%2BD1cXhsVOmsr4%3D 10.1016/S1470-2045(08)70027-5 18237849 (Pubitemid 351150126)
6. A Walther E Johnstone C Swanton, et al. 2009 Genetic prognostic and predictive markers in colorectal cancer Nat Rev Cancer 9 489 499 1:CAS:528:DC%2BD1MXnsVagtbY%3D 10.1038/nrc2645 19536109
7. WM Cong A Bakker PA Swalsky, et al. 2001 Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study J Cancer Res Clin Oncol 127 187 192 1:CAS:528:DC%2BD3MXhtVGgtrk%3D 10.1007/s004320000194 11260864 (Pubitemid 32449070)
8. T Soussi 2000 The p53 tumor suppressor gene: from molecular biology to clinical investigation Ann N Y Acad Sci 910 121 137 1:CAS:528: DC%2BD3cXlsVOjt74%3D 10.1111/j.1749-6632.2000.tb06705.x 10911910
9. DG Kirsch MB Kastan 1998 Tumor-suppressor p53: implications for tumor development and prognosis J Clin Oncol 16 3158 3168 1:CAS:528:DyaK1cXmtFSlsbw%3D 9738588 (Pubitemid 28417439)
10. E Steels M Paesmans T Berghmans, et al. 2001 Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur Respir J 18 705 719 1:CAS:528:DC%2BD3MXpt1Kisrw%3D 10.1183/09031936.01.00062201 11716177 (Pubitemid 33040631)
11. R Havlik E Sbisà A Tullo, et al. 2000 Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors Hepatogastroenterology 47 927 931 1:STN:280:DC%2BD3cvmslCltA%3D%3D 11020850
12. AM Rijken GJ Offerhaus MM Polak, et al. 1999 p53 expression as a prognostic determinant in resected distal bile duct carcinoma Eur J Surg Oncol 25 297 301 1:STN:280:DyaK1M3ntVyksw%3D%3D 10.1053/ejso.1998.0645 10336811 (Pubitemid 29261292)
13. Q Cheng X Luo B Zhang, et al. 2007 Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases Ann Surg Oncol 14 1212 1219 10.1245/s10434-006-9260-0 17176983
14. P Argani A Shaukat M Kaushal, et al. 2001 Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts Cancer 91 1332 1341 1:CAS:528:DC%2BD3MXislyhtbs%3D 10.1002/1097-0142(20010401)91:7<1332::AID-CNCR1136>3.0.CO;2-4 11283934 (Pubitemid 32267045)
15. T Suto T Sugai S Nakamura, et al. 1998 Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct Cancer 82 86 95 1:CAS:528: DyaK1cXltlKgsA%3D%3D 10.1002/(SICI)1097-0142(19980101)82:1<86::AID- CNCR10>3.0.CO;2-9 9428483 (Pubitemid 28070483)
16. YC Lee SY Song JB Chung, et al. 1996 p53 protein expression in extrahepatic bile duct cancer Yonsei Med J 37 112 117 1:CAS:528: DyaK28XltVagt70%3D 8711933 (Pubitemid 126450974)
17. D Santini G Tonini FM Vecchio, et al. 2005 Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma J Clin Pathol 58 159 165 1:STN:280:DC%2BD2M%2FltVWjuw%3D%3D 10.1136/jcp.2004.018887 15677536 (Pubitemid 40193801)
18. MKB Parmar V Torri L Stewart 1998 Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 2815 2834 1:STN:280:DyaK1M7itVWksA%3D%3D 10.1002/(SICI)1097- 0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8 9921604 (Pubitemid 28562978)
19. AJ Munro S Lain DP Lane 2005 P53 abnormalities and outcomes in colorectal cancer: a systematic review Br J Cancer 92 434 444 1:CAS:528: DC%2BD2MXhtFWntr0%3D 15668707 (Pubitemid 40395523)
20. PD Pharoah NE Day C Caldas 1999 Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis Br J Cancer 80 1968 1973 1:STN:280:DyaK1MzpslKnug%3D%3D 10.1038/sj.bjc.6690628 10471047 (Pubitemid 29391282)
21. M Huncharek B Kupelnick JF Geschwind, et al. 2000 Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies Cancer Lett 153 219 226 1:CAS:528: DC%2BD3cXisFGlsr4%3D 10.1016/S0304-3835(00)00381-5 10779652 (Pubitemid 30209865)
22. JF Tierney LA Stewart D Ghersi, et al. 2007 Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 16 31 10.1186/1745-6215-8-16 17555582 (Pubitemid 47161711)
23. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
24. T Suto T Sugai S Nakamura, et al. 1997 Immunohistochemical detection of proliferating cell nuclear antigen and p53 expression in carcinoma of the extrahepatic bile duct Oncology 54 407 413 1:CAS:528:DyaK2sXls1CmtL0%3D 10.1159/000227727 9260603 (Pubitemid 27321120)
25. MP Hoang LA Murakata N Katabi, et al. 2002 Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases Mod Pathol 15 1251 1258 10.1097/01.MP.0000036450.61830.8E 12481004 (Pubitemid 35462991)
26. J Albores-Saavedra L Murakata JE Krueger, et al. 2000 Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts Cancer 89 508 515 1:STN:280:DC%2BD3cvgt1aktw%3D%3D 10.1002/1097-0142(20000801)89: 3<508::AID-CNCR5>3.0.CO;2-D 10931449 (Pubitemid 30640097)
27. X Li AM Hui T Takayama, et al. 2000 Altered p21WAF1/CIP1 expression is associated with poor prognosis in extrahepatic bile duct carcinoma Cancer Lett 154 85 91 1:CAS:528:DC%2BD3cXivVGgsb0%3D 10.1016/S0304-3835(00)00383-9 10799743 (Pubitemid 30229913)
28. M Takashima T Ueki E Nagai, et al. 2000 Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions Mod Pathol 13 1300 1307 1:STN:280:DC%2BD3M7ivFahtw%3D%3D 10.1038/modpathol.3880238 11144926 (Pubitemid 32014667)
29. SH Park YI Kim YH Park, et al. 2000 Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater World J Surg 24 54 59 1:STN:280:DC%2BD3c%2FmtlersA%3D%3D 10.1007/s002689910011 10594204
30. CD Mann CP Neal G Garcea, et al. 2007 Prognostic molecular markers in hepatocellular carcinoma: a systematic review Eur J Cancer 43 979 992 1:CAS:528:DC%2BD2sXjslGnurY%3D 10.1016/j.ejca.2007.01.004 17291746 (Pubitemid 46483030)
31. AJ Levine 1992 The p53 tumor-suppressor gene N Engl J Med 326 1350 1352 1:STN:280:DyaK383ivVShuw%3D%3D 10.1056/NEJM199205143262008 1565147
32. N Scott P Sagar J Stewart, et al. 1991 p53 in colorectal cancer: clinicopathological correlation and prognostic significance Br J Cancer 63 317 319 1:STN:280:DyaK3M7ksFWhsw%3D%3D 10.1038/bjc.1991.74 1997114
33. P Wong SJ Verselis JE Garber, et al. 2006 Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome Gastroenterology 130 73 79 10.1053/j.gastro.2005.10.014 16401470 (Pubitemid 43049837)
34. T Soussi C Béroud 2003 Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides Hum Mutat 21 192 200 1:CAS:528:DC%2BD3sXis1yjtrw%3D 10.1002/humu.10189 12619105 (Pubitemid 36292962)
35. T Soussi 2007 p53 alterations in human cancer: more questions than answers Oncogene 26 2145 2156 1:CAS:528:DC%2BD2sXjs1yqt7s%3D 10.1038/sj.onc.1210280 17401423 (Pubitemid 46536642)
36. PA Kyzas D Denaxa-Kyza JP Ioannidis 2007 Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect J Natl Cancer Inst 99 236 243 10.1093/jnci/djk032 17284718
37. PA Kyzas KT Loizou JP Ioannidis 2005 Selective reporting biases in cancer prognostic factor studies J Natl Cancer Inst 97 1043 1055 10.1093/jnci/dji184 16030302 (Pubitemid 41417921)
38. WR Jarnagin DS Klimstra M Hezel, et al. 2006 Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome J Clin Oncol 24 1152 1160 1:CAS:528:DC%2BD28XislGgsbY%3D 10.1200/JCO.2005.04.6631 16505435 (Pubitemid 46638813)
39. K Caca J Feisthammel K Klee, et al. 2002 Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines Int J Cancer 97 481 488 1:CAS:528:DC%2BD38XkvFegtA%3D%3D 10.1002/ijc.1639 11802210 (Pubitemid 34027807)
40. SA Khan HC Thomas MB Toledano, et al. 2005 p53 Mutations in human cholangiocarcinoma: a review Liver Int 25 704 716 1:CAS:528:DC%2BD2MXpsVansLY%3D 10.1111/j.1478-3231.2005.01106.x 15998419 (Pubitemid 41038651)
41. A Petitjean MI Achatz AL Borresen-Dale, et al. 2007 TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes Oncogene 26 2157 2165 1:CAS:528:DC%2BD2sXjs1yqtL4%3D 10.1038/sj.onc.1210302 17401424 (Pubitemid 46536647)
42. N Malats A Bustos CM Nascimento, et al. 2005 P53 as a prognostic marker for bladder cancer: a meta-analysis and review Lancet Oncol 6 678 686 1:CAS:528:DC%2BD2MXpslynsro%3D 10.1016/S1470-2045(05)70315-6 16129368 (Pubitemid 41222758)
43. AM Bode Z Dong 2004 Post-translational modification of p53 in tumorigenesis Nat Rev Cancer 4 793 805 1:CAS:528:DC%2BD2cXos1ymu7o%3D 10.1038/nrc1455 15510160 (Pubitemid 39331151)
44. G Della Torre G Pasquini S Pilotti, et al. 2000 TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas Diagn Mol Pathol 9 41 46 1:STN:280:DC%2BD3c7otFWnsg%3D%3D 10.1097/00019606-200003000-00007 10718212 (Pubitemid 30131961)
45. T Stiewe 2007 The p53 family in differentiation and tumorigenesis Nat Rev Cancer 7 165 168 1:CAS:528:DC%2BD2sXitVGrsb8%3D 10.1038/nrc2072 17332760
46. AI Zaika W El-Rifai 2006 The role of p53 protein family in gastrointestinal malignancies Cell Death Differ 13 935 940 1:CAS:528: DC%2BD28Xks1OrtL0%3D 10.1038/sj.cdd.4401897 16557273
47. MP Deyoung LW Ellisen 2007 p63 and p73 in human cancer: defining the network Oncogene 26 5169 5183 1:CAS:528:DC%2BD2sXoslagtLc%3D 10.1038/sj.onc.1210337 17334395 (Pubitemid 47237632)
48. SM Hong H Cho CA Moskaluk, et al. 2007 p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance J Mol Histol 38 167 175 1:CAS:528:DC%2BD2sXls1Sguro%3D 10.1007/s10735-007-9084-7 17385050 (Pubitemid 46980549)